Skip to content
Tuesday, November 17, 2026
Diamond Insight

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Agreement Because of Data Concerns

Health funding illustration
The offered American funding was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a major American healthcare agreement valued at 367 million US dollars (£272m) over five years due to the United States' request for sensitive data.

This rejection came to light after a official document dated December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "skewed".

An official representative later clarified that the United States was demanding access to biological samples for scientific study and profit while was unwilling to guarantee the resulting advantages from any future medical innovations.

"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged continued dialogue to find a agreement acceptable to both sides so the country's vital HIV programme can be sustained.

Broader Context

This rejection follows a comparable case in neighbouring Kenya, where a court suspended a related health funding agreement following concerns were filed about the safety of citizens' health data.

After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and responsibility.

According to statements, 16 nations in Africa have so far signed similar health pacts, constituting more than $18.3bn in new funding.

Details of the Declined Agreement

This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported programmes," Tremont said.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Our nation was requested to provide its genetic material and health information over an extended period, with no equivalent assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," his statement read.

"In essence, our nation would supply the raw materials for medical research with no certainty that the final treatments would be available to our population should a new pandemic arise."

National Interest and Global Health

Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting structures previously set up via the global organization.

The spokesperson cited its Pandemic Benefit-Sharing system created to deal with potential pandemics.

"This system is designed to ensure that when a country provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."

The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We encourage continued discussions with our US partners on how future collaboration could be arranged in a manner that honours the independence and dignity of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but urged that negotiations need to persist given that a large portion of the country's Aids initiatives were funded by external financing.

"If specific concerns exist, such as those involving information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group said.

This impasse underscores the complex challenges between accepting vital foreign assistance and safeguarding a country's data in an ever more data-driven world.

The writer

Thomas Sanders

A certified gemologist with over 15 years of experience in diamond appraisal and sustainable jewelry sourcing.

Diamond Insight

Type to search articles.